Casey Janet R, Pichichero Michael E
University of Rochester School of Medicine, Elmwood Pediatric Group, Rochester, New York, USA.
Clin Pediatr (Phila). 2007 May;46(4):307-10. doi: 10.1177/0009922806293919.
The frequency of symptomatic relapses following various antibiotic treatments for group A beta-hemolytic streptococcal tonsillopharyngitis was evaluated in 1080 pediatric patients. Within 5 days of completing therapy, the rank-order frequency of treatment failures was (1) penicillin, (2) amoxicillin, (3) first-generation cephalosporins, (4) beta-lactamase stable cephalosporins and amoxicillin-clavulanate ( P = .005). Retreatment of symptomatic failures resulted in another symptomatic relapse more often with penicillin than with cephalosporins (P = .02). Clinicians should be aware that the rate of symptomatic failures after antibiotic therapy for group A beta-hemolytic streptococcal tonsillopharyngitis differs by drug and is not an uncommon event.
在1080名儿科患者中评估了各种抗生素治疗A组β溶血性链球菌扁桃体咽炎后症状性复发的频率。在完成治疗的5天内,治疗失败的频率排序为:(1)青霉素,(2)阿莫西林,(3)第一代头孢菌素,(4)β-内酰胺酶稳定的头孢菌素和阿莫西林-克拉维酸盐(P = 0.005)。有症状性失败的再治疗导致症状性复发,使用青霉素比使用头孢菌素更常见(P = 0.02)。临床医生应意识到,A组β溶血性链球菌扁桃体咽炎抗生素治疗后症状性失败的发生率因药物而异,且并非罕见事件。